MAR 09, 2017 7:49 PM PST

T Cells "Loosen Up" to Recognize Pathogens Better and Faster

WRITTEN BY: Kara Marker

Senior author of a new Science Signaling study Dr. Manish Butte describes T cells as like “the shy person at the office holiday party who acts stiff until they loosen up a bit.” Butte is talking about T cells interacting with antigen-presenting cells, because the reaction between these two literally depends on whether T cells are loose or stiff.

T cells are produced in the thymus and promote cell-mediated immune response, also known as the adaptive immune response. Credit: Pulmonary Fibrosis News

Antigen-presenting cells (APCs) display bits of pathogenic or cancerous proteins, waiting for T cells that are designed to recognize the specific antigens they are displaying on their cell surface in order to trigger an immune response. A T cell interaction with an antigen-presenting cell (APC) occurs in three steps.

  1. The initial fraternization: A T cell binds to an APC to see if there is a match

  2. The identification: The T cell recognizes an antigen on an APC and communicates with the APC to find other potential nearby APCs displaying the same antigen

  3. The activation: As the T cell continues to bind to the APC, it becomes activated, a process necessary for T cells to dive into the bloodstream prepared to find the pathogen the APC was trying to warn the T cell about

With these steps fully understood, Butte and other researchers from the University of California Los Angeles Health Sciences turned to investigate another factor that matters in the scheme of the immune response: the stiffness or softness of the T cells; stiff cells react more slowly to activation than soft cells.

"Until now, we had a limited understanding of what controls T cell activation," Butte explained. "We wanted to identify how to both encourage and speed up T cell activation for fighting infections and cancers and to disrupt it in order to prevent immune disease. Now that we understand the precise steps taking place, our findings suggest that altering T cell stiffness with drugs could one day help us thwart diseases where T cells are too active or not active enough."

Butte introduced a new approach to observe T cell activity in real-time at the nano-level: a technology called an atomic-force microscope. This approach helped them identify the pathway in charge of a T cell being stiff instead of soft, allowing a future opportunity for the development of drugs that can mimic the natural pathway toward T cell softness, introducing an entirely new way to manipulate the immune system.

"We can't talk about precision medicine and still use a sledgehammer to treat disease," Butte said. "By exploiting the mechanism we discovered to soften T cells, we could accelerate vaccine responses so a patient won't need multiple boosters and months of waiting to get full immunity. Or we could stiffen up T cells to prevent the body from rejecting transplanted organs."

Source: University of California Los Angeles Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 25, 2021
Immunology
The Immune System Impairs Antibiotic Effectiveness
MAR 25, 2021
The Immune System Impairs Antibiotic Effectiveness
Nitric oxide, a molecule produced by the immune system, can negatively impact antibiotics’ effectiveness, says a s ...
APR 21, 2021
Immunology
Human T Cells Can't Recognize COVID Mutants
APR 21, 2021
Human T Cells Can't Recognize COVID Mutants
Genetic variants of the SARS-CoV-2 virus have emerged and tightened their grip on global communities as the pandemic rag ...
APR 22, 2021
Drug Discovery & Development
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
APR 22, 2021
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work wit ...
APR 27, 2021
Immunology
Breakthrough Malaria Vaccine Is a Ray of Hope
APR 27, 2021
Breakthrough Malaria Vaccine Is a Ray of Hope
University of Oxford scientists have developed a vaccine against malaria, which they describe as having “unprecede ...
MAY 12, 2021
Immunology
Illuminating the COVID-19 Disease Profile Puzzle
MAY 12, 2021
Illuminating the COVID-19 Disease Profile Puzzle
Teams of science experts from numerous disciplines have been collecting data on SARS-CoV-2 for over a year to understand ...
MAY 18, 2021
Immunology
A Silver Bullet Against COVID Variants?
MAY 18, 2021
A Silver Bullet Against COVID Variants?
Canadian researchers have discovered an antiviral drug that blocks the SARS-CoV-2 virus from infecting lung cells. Promi ...
Loading Comments...